000 05107nam a22005055i 4500
001 978-1-60327-824-9
003 DE-He213
005 20140220083734.0
007 cr nn 008mamaa
008 101202s2011 xxu| s |||| 0|eng d
020 _a9781603278249
_9978-1-60327-824-9
024 7 _a10.1007/978-1-60327-824-9
_2doi
050 4 _aRJ1-570
072 7 _aMJW
_2bicssc
072 7 _aMED069000
_2bisacsh
082 0 4 _a618.92
_223
100 1 _aFlynn, Joseph T.
_eeditor.
245 1 0 _aPediatric Hypertension
_h[electronic resource] /
_cedited by Joseph T. Flynn, Julie R. Ingelfinger, Ronald J. Portman.
264 1 _aTotowa, NJ :
_bHumana Press,
_c2011.
300 _aVIII, 692p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aClinical Hypertension and Vascular Diseases
505 0 _aPART I. Regulation of Blood Pressure in Children -- Chapter 1: Neurohumoral Regulation of Blood Pressure in Early Development -- Chapter 2: Vasoactive Factors and Blood Pressure in Children -- Chapter 3: Cardiovascular and Autonomic Influences on Blood Pressure -- Chapter 4: Ions and Fluid Dynamics in Hypertension -- Chapter 5: CRP, Uric Acid and Other Novel Factors in th Pathogenesis of Hypertension -- Chapter 6: Monogenic and Polygenic Genetic Contributions to Hypertension -- PART II. Assessment of Blood Pressure in Children: Measurement, Normative Data, Epidemiology -- Chapter 7: Casual Blood Pressure Methodology -- Chapter 8: Development of Blood Pressure Norms in Children -- Chapter 9: Definitions of Hypertension in Children -- Chapter 10: Ambulatory Blood Pressure Monitoring and Norms in Children -- Chapter 11: Epidemiology of Essential Hypertension in Chlidren: The Bogalusa Heart Study -- Chapter 12: Epidemiology of Cardiovascular Disease in Children -- PART III. Hypertension in Children: Predictors, Risk Factors, and Special Populations -- Chapter 13: Perinatal Programming and Blood Pressure -- Chapter 14: Familial Aggregation of Blood Pressure -- Chapter 15: Influence of Dietary Electrolytes on Childhood Blood Pressure -- Chapter 16: Ethnic Differences in Childhood Blood Pressure -- Chapter 17: Childhood Obesity and Blood Pressure Regulation -- Chapter 18: Hypertension in children with the metabolic syndrome or type 2 diabetes -- Chapter 19: Primary Hypertension in Children -- Chapter 20: Secondary Forms of Hypertension in Children -- Chapter 21: Neonatal Hypertension -- Chapter 22: Hypertension in Chronic Kidney Disease -- Chapter 23: Hypertension in End-Stage Renal Disease -- Chapter 24: Sequelae of Hypertension in Children and Adolescents -- Chapter 25: Sleep Apnea and Hypertension -- Chapter 26: Hypertension and Exercise -- Chapter 27: Hypertension in the Developing World -- PART IV. Evaluation and Management of Pediatric Hypertension -- Chapter 28: Evaluation of the Hypertensive Pediatric Patient -- Chapter 29: The Role of Ambulatory Blood Pressure Monitoring in Diagnosis of Hypertension and Evaluation of Target-organ Damage -- Chapter 30: Nonpharmacologic Treatment of Pediatric Hypertension -- Chapter 31: Pharmacotherapy of Pediatric Hypertension -- Chapter 32: Management of Hypertensive Emergencies -- Chapter 33: Pediatric Antihypertensive Clinical Trials.
520 _aThis outstanding second edition amplifies and improves this premier text on hypertension in neonates, children, and adolescents. Previous chapters have been fully revised and new chapters have been added to cover important topics of recent interest, such as the metabolic syndrome, the impact of exercise on blood pressure, the many uses of ambulatory monitoring, and the relationship of sleep disorders to hypertension. A comprehensive volume, this book features 32 chapters covering the breadth and depth of the current knowledge. It is divided into 4 sections: blood pressure regulation and hypertension pathophysiology; assessment of blood pressure; predictors, risk factors, and special populations; and evaluation and management. Filled with excellent detail and pragmatic information, Pediatric Hypertension, Second Edition includes therapeutic guidelines from the US National High Blood Pressure Education Program and cutting edge data from clinical antihypertensive trials. Trainees as well as practicing clinicians will find the updated information on current treatments especially useful.
650 0 _aMedicine.
650 0 _aCardiology.
650 0 _aNephrology.
650 0 _aPediatrics.
650 1 4 _aMedicine & Public Health.
650 2 4 _aPediatrics.
650 2 4 _aNephrology.
650 2 4 _aCardiology.
700 1 _aIngelfinger, Julie R.
_eeditor.
700 1 _aPortman, Ronald J.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781603278232
830 0 _aClinical Hypertension and Vascular Diseases
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-60327-824-9
912 _aZDB-2-SME
999 _c106333
_d106333